Skip to main content
Article
The Effects of Medetomidine on Cardiac Function in Normal Cats Measured by Radionuclide Ventriculography
Veterinary Anaesthesia and Analgesia (1997)
  • G. B. Daniel
  • L. Golden
  • D. Fefee
  • K. Young
  • G. Schmidt
  • Ralph C. Harvey, University of Tennessee, Knoxville
Abstract
To assess the effects of medetomidine, an α2-adrenoceptor agonist, on cardiac function, radionuclide ventriculograms (RNV) were performed in 7 normal anesthetised cats before and after im administration of the drug. Ejection fraction (EF), peak ventricular ejection rate (PVER), peak ventricular filling rate (PVFR), time to peak ejection (TPE) and time to peak filling (TPF) were determined. Medetomidine caused significant reductions in EF (baseline 55.0 ± 10.8%, post medetomidine 43.3 ± 10.7%), PVER (baseline 4.38 ± 0.83 EDV/s, post medetomidine 3.28 ± 0.73 EDV/s) and PVFR (baseline 4.46 ± 1.42 EDV/s, post medetomidine 3.05 ± 1.27 EDV/s). There was also a significant decrease in heart rate following medetomidine administration (baseline 115 ± 27.2 bpm, post medetomidine 100 ± 21.2 bpm). The TPE and TPF did not change significantly following medetomidine. The observed decrease in cardiac function may have been caused by a drug-induced increase in systemic vascular resistance, and the bradycardia due to central nervous system depression.
Publication Date
December, 1997
Citation Information
G. B. Daniel, L. Golden, D. Fefee, K. Young, et al.. "The Effects of Medetomidine on Cardiac Function in Normal Cats Measured by Radionuclide Ventriculography" Veterinary Anaesthesia and Analgesia Vol. 24 Iss. 2 (1997)
Available at: http://works.bepress.com/ralph_harvey/13/